SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-005905
Filing Date
2024-09-25
Accepted
2024-09-24 18:13:38
Documents
33
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q agtx_10q.htm   iXBRL 10-Q 349355
2 CERTIFICATION agtx_ex311.htm EX-31.1 13078
3 CERTIFICATION agtx_ex312.htm EX-31.2 13052
4 CERTIFICATION agtx_ex321.htm EX-32.1 5352
  Complete submission text file 0001477932-24-005905.txt   1615103

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agtx-20240630.xsd EX-101.SCH 16417
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agtx-20240630_lab.xml EX-101.LAB 109603
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agtx-20240630_cal.xml EX-101.CAL 24406
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agtx-20240630_pre.xml EX-101.PRE 83207
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agtx-20240630_def.xml EX-101.DEF 29520
36 EXTRACTED XBRL INSTANCE DOCUMENT agtx_10q_htm.xml XML 118492
Mailing Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629
Business Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629 321-229-2014
Agentix Corp. (Filer) CIK: 0001603345 (see all company filings)

IRS No.: 462876282 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55383 | Film No.: 241321007
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)